Skip to content
Nutriband
  • Home
  • About
    • Management
    • Board of Directors
    • Advisory Board
    • Careers
    • Investors
  • Pipeline
  • Capabilities
  • News
  • Contact Us

Gareth Sheridan – Nutriband

Post navigation
← Previous Media

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Nutriband Supports Update to CDC Opioid Prescribing Guidelines
  • Nutriband Inc. to Present at the Emerging Growth Conference on May 25
  • Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
  • Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
  • Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
Nutriband - Logo - Leaders in Transdermal Technology

Its our goal to improve patient comfort, safety and efficacy while setting new safety standards for notoriously abused, yet extremely effective medications!

Linkedin Twitter Facebook

Quick Links

  • Home
  • About Us
  • Our Pipeline
  • Capabilities
  • 4P Therapeutics
  • Pocono Pharma

Company Info

  • NTRB Filings
  • NTRB Stock Info
  • NTRB Investor Info
  • Management Team
  • Latest Press Releases
  • Privacy and Cookies Policy
  • NTRB and GDPR

Contact Info

Nutriband Pharma
121 S. Orange Ave.,
Suite 1500,
Orlando,
FL 32801
[email protected]

Copyright © 2022 Nutriband
Powered by Trigger Media